sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Europe Microbiome Therapeutics Market...

Previsioni di mercato per le terapie del microbioma in Europa fino al 2030 - Analisi regionale - per tipologia (terapie e procedure), applicazione (disturbi metabolici e obesità, infezione da C. difficile, malattie infiammatorie intestinali e altre) e utente finale (ospedali e cliniche, centri chirurgici ambulatoriali , Assistenza domiciliare e altri)

BMIRE00029955 | Pages: 71 | Pharmaceuticals | Apr 2024 | Type: Regional | Status: Published
Il mercato europeo delle terapie per il microbioma è stato valutato a 97,74 milioni di dollari nel 2022 e si prevede che raggiungerà i 212,52 milioni di dollari entro il 2030; si stima che registrerà un CAGR del 10,2% dal 2022 al 2030. L’afflusso di fondi per migliorare la pipeline di scoperta del microbioma spinge l’Europa Microbiome Therapeutics Una ricerca di mercato ha dimostrato che squilibri o interruzioni nel microbioma possono contribuire a varie condizioni, come le malattie infiammatorie intestinali e obesità e disturbi di salute mentale. Il riconoscimento del ruolo del microbioma nella salute generale ha generato un interesse significativo nello sviluppo di terapie mirate e modulanti il microbioma. Inoltre, i progressi nella tecnologia e negli strumenti di ricerca hanno reso più facile studiare e manipolare il microbioma. Il sequenziamento di nuova generazione e l’analisi metagenomica hanno consentito una comprensione più profonda delle comunità microbiche e delle loro funzioni. La maggiore conoscenza ha aperto nuove possibilità per lo sviluppo di terapie mirate. Ad esempio, nel marzo 2023, ambiomics GmbH, un’azienda tedesca di biotecnologie sul microbioma, ha sviluppato la prima generazione di terapie efficaci basate sul microbioma. Ha ricevuto un finanziamento di 13 milioni (15 milioni di dollari) da MIG Capital. Il finanziamento consentirà di costruire la piattaforma, che accelererà l’identificazione dei candidati farmaci di prima scelta e accelererà gli sforzi di ricerca verso la validazione clinica. Man mano che diventano disponibili solide prove cliniche, gli investitori stanno iniziando a prestare attenzione alle aziende che modulano il microbioma. L’aumento dei finanziamenti fornisce alle aziende le risorse necessarie per superare le sfide associate agli elevati costi di sviluppo e produzione, facendo avanzare il settore. Panoramica del mercato europeo dei prodotti terapeutici per il microbioma Le società di ricerca terapeutica sul microbioma in Germania si concentrano nel chiamare altre società a investire nelle loro attività di ricerca per migliorare la qualità della ricerca condotta per lo sviluppo di prodotti sul microbioma. Nel marzo 2023, mbiomics GmbH, una società biotecnologica tedesca focalizzata sul microbioma, ha ricevuto circa 15 milioni di dollari (13 milioni) in un round di finanziamento di serie A guidato da MIG Capital. mbiomics ha utilizzato i proventi per intraprendere partnership strategiche, espandendo in modo significativo le proprie strutture di laboratorio a Monaco e i team di ricerca e sviluppo in Germania. In alcune procedure FMT, gli agenti infettivi possono essere trasferiti dal donatore al paziente, il che influisce sui risultati. Pertanto, la Germania ha stabilito norme particolari per l’uso del microbioma o delle procedure FMT. In Germania i farmaci FMT sono regolamentati come medicinali; tuttavia, l’uso di questo prodotto può essere effettuato solo quando nessun altro trattamento funziona su condizioni quali infezioni da C. difficile e infezioni intestinali. Pertanto, nonostante l’aumento degli investimenti nella ricerca sulle terapie per il microbioma, le normative riguardanti l’uso di questi prodotti terapeutici potrebbero ostacolare la crescita del mercato europeo delle terapie per il microbioma in Germania. Entrate e previsioni del mercato europeo delle terapie per il microbioma fino al 2030 (milioni di dollari) Segmentazione del mercato europeo delle terapie per il microbioma Il mercato europeo delle terapie per il microbioma è segmentato in base al tipo, all\'applicazione, all\'utente finale e al paese. In base alla tipologia, il mercato europeo delle terapie per il microbioma è suddiviso in terapie e procedure. Il segmento delle procedure ha detenuto una quota maggiore nel 2022. Il segmento delle terapie è ulteriormente suddiviso in trapianto di microbiota fecale (FMT), prebiotici e probiotici e altri. Per applicazione, il mercato europeo delle terapie per il microbioma è segmentato in disturbi metabolici e obesità, infezione da C. difficile, malattie infiammatorie intestinali e altri. Il segmento dei disturbi metabolici e dell’obesità ha detenuto la quota maggiore nel 2022. Per utente finale, il mercato europeo delle terapie per il microbioma comprende ospedali e cliniche, centri chirurgici ambulatoriali, assistenza domiciliare e altri. Il segmento degli ospedali e delle cliniche ha detenuto la quota maggiore nel 2022. In base al paese, il mercato europeo delle terapie per il microbioma è segmentato in Regno Unito, Germania, Francia, Italia, Spagna e resto d\'Europa. La Germania ha dominato il mercato europeo delle terapie per il microbioma nel 2022. Caelus Health BV, Enterome SA, Ferring Holdings SA, Vedanta Biosciences Inc e YSOPIA Bioscience SA sono alcune delle aziende leader che operano nel mercato europeo delle terapie per il microbioma.
Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Microbiome Therapeutics Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

5. Europe Microbiome Therapeutics Market - Key Industry Dynamics

5.1 Europe Microbiome Therapeutics Market - Key Industry Dynamics

5.2 Key Market Drivers

5.2.1 Potential of Gut Microbiota in Maintaining Human Health

5.2.2 Inflow of Funds to Ameliorate Microbiome Discovery Pipeline

5.3 Key Market Restraints

5.3.1 High Cost of Development and Production

5.4 Key Market Opportunities

5.4.1 Increasing R&D to Gain Better Understanding of Human Microbiome

5.5 Key Future Trends

5.5.1 Technological Advancement in Human Microbiome Therapeutics

5.6 Impact of Drivers and Restraints:

6. Microbiome Therapeutics Market - Europe Market Analysis

7. Europe Microbiome Therapeutics Market Analysis - Type

7.1 Therapeutics

7.1.1 Overview

7.1.2 Therapeutics Market, Revenue and Forecast to 2030 (US$ Thousand)

7.2 Procedure

7.2.1 Overview

7.2.2 Procedure Market, Revenue and Forecast to 2030 (US$ Thousand)

8. Europe Microbiome Therapeutics Market Analysis - Application

8.1 Metabolic Disorder and Obesity

8.1.1 Overview

8.1.2 Metabolic Disorder and Obesity Market, Revenue and Forecast to 2030 (US$ Thousand)

8.2 C. Difficile Infection (CDI)

8.2.1 Overview

8.2.2 C. Difficile Infection (CDI) Market, Revenue and Forecast to 2030 (US$ Thousand)

8.3 Inflammatory Bowel Disease

8.3.1 Overview

8.3.2 Inflammatory Bowel Disease Market, Revenue and Forecast to 2030 (US$ Thousand)

8.4 Others

8.4.1 Overview

8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)

9. Europe Microbiome Therapeutics Market Analysis - End User

9.1 Hospitals and Clinics

9.1.1 Overview

9.1.2 Hospitals and Clinics Market, Revenue and Forecast to 2030 (US$ Thousand)

9.2 Ambulatory Surgical Centers

9.2.1 Overview

9.2.2 Ambulatory Surgical Centers Market, Revenue and Forecast to 2030 (US$ Thousand)

9.3 Homecare

9.3.1 Overview

9.3.2 Homecare Market, Revenue and Forecast to 2030 (US$ Thousand)

9.4 Others

9.4.1 Overview

9.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)

10. Europe Microbiome Therapeutics Market - Country Analysis

10.1. Europe Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country

10.1.1 Europe Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country

10.1.2 UK

10.1.2.1 UK: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.2.2 United Kingdom Europe Microbiome Therapeutics Market Breakdown by Type

10.1.2.2.1 UK: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.2.3 UK: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.2.4 UK: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.3 Germany

10.1.3.1 Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.3.2 Germany: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.3.2.1 Germany: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.3.3 Germany: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.3.4 Germany: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.4 France

10.1.4.1 France: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.4.2 France: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.4.2.1 France: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.4.3 France: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.4.4 France: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.5 Italy

10.1.5.1 Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.5.2 Italy: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.5.2.1 Italy: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.5.3 Italy: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.5.4 Italy: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.6 Spain

10.1.6.1 Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.6.2 Spain: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.6.2.1 Spain: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.6.3 Spain: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.6.4 Spain: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.7 Rest of Europe

10.1.7.1 Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.7.2 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.7.2.1 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.7.3 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.7.4 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by End User

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in Europe Microbiome Therapeutics Market

12. Company Profiles

12.1 YSOPIA Bioscience SA

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Ferring Holdings SA

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Enterome SA

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Caelus Health BV

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Vedanta Biosciences Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. Europe Microbiome Therapeutics Market Segmentation

Table 2. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Type

Table 3. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Therapeutics

Table 4. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Application

Table 5. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - End User

Table 6. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Country

Table 7. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 8. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 9. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 10. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 11. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 12. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 13. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 14. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 15. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 16. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 17. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 18. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 19. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 20. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 21. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 22. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 23. ADULT OBESITY, 2030

Table 24. CHILD OBESITY, 2030

Table 25. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 26. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 27. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 28. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 29. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 30. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 31. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 32. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 33. Recent Growth Strategies in Europe Microbiome Therapeutics Market

Table 34. Glossary of Terms, Europe Microbiome Therapeutics Market

List of Figures

Figure 1. Europe Microbiome Therapeutics Market Segmentation, By Country

Figure 2. Europe PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Europe Microbiome Therapeutics Market Revenue (US$ Thousand), 2022 - 2030

Figure 5. Europe Microbiome Therapeutics Market Share (%) - Type, 2022 and 2030

Figure 6. Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 7. Procedure Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 8. Europe Microbiome Therapeutics Market Share (%) - Application, 2022 and 2030

Figure 9. Metabolic Disorder and Obesity Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 10. C. Difficile Infection (CDI) Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 11. Inflammatory Bowel Disease Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 12. Others Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 13. Europe Microbiome Therapeutics Market Share (%) - End User, 2022 and 2030

Figure 14. Hospitals and Clinics Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 15. Ambulatory Surgical Centers Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 16. Homecare Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 17. Others Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 18. Europe Microbiome Therapeutics Market Breakdown by Key Countries - Revenue (2022) (US$ Thousand)

Figure 19. Europe Microbiome Therapeutics Market Breakdown by Key Countries, 2022 and 2030 (%)

Figure 20. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 21. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 22. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 23. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 24. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 25. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

1. Caelus Health BV

2. Enterome SA

3. Ferring Holdings SA

4. Vedanta Biosciences Inc

5. YSOPIA Bioscience SA

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe microbiome therapeutics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Europe microbiome therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the microbiome therapeutics market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
    • Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports
    Report Name Published Date
    Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022
    Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022
    Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022
    Purchase Options
    Single User License
    $3550
    $2840
    Site License
    $4550
    $3640
    Enterprise License
    $5550
    $4440
    GET FREE SAMPLE PDF
    Inquire before Buying Inquire for Discount
    Subscription Member Price: FREE
    Get Subscription